Glioma targeted therapy: insight into future of molecular approaches

K Yang, Z Wu, H Zhang, N Zhang, W Wu, Z Wang… - Molecular Cancer, 2022 - Springer
Gliomas are the common type of brain tumors originating from glial cells. Epidemiologically,
gliomas occur among all ages, more often seen in adults, which males are more susceptible …

Revisiting platinum-based anticancer drugs to overcome gliomas

J Jeon, S Lee, H Kim, H Kang, HS Youn, S Jo… - International journal of …, 2021 - mdpi.com
Although there are many patients with brain tumors worldwide, there are numerous
difficulties in overcoming brain tumors. Among brain tumors, glioblastoma, with a 5-year …

Integrated response analysis of pediatric low-grade gliomas during and after targeted therapy treatment

JW Tsai, JJ Choi, H Ouaalam, EA Murillo… - Neuro-Oncology …, 2023 - academic.oup.com
Background Pediatric low-grade gliomas (pLGGs) are the most common central nervous
system tumor in children, characterized by RAS/MAPK pathway driver alterations. Genomic …

Pediatric and adult low-grade gliomas: where do the differences lie?

L Greuter, R Guzman, J Soleman - Children, 2021 - mdpi.com
Two thirds of pediatric gliomas are classified as low-grade (LGG), while in adults only
around 20% of gliomas are low-grade. However, these tumors do not only differ in their …

[HTML][HTML] The mechanisms of current platinum anticancer drug resistance in the glioma

E Lu, I Gareev, C Yuan, Y Liang, J Sun… - Current …, 2022 - ncbi.nlm.nih.gov
Gliomas are the most common and malignant primary tumors of the central nervous system
(CNS). Glioblastomas are the most malignant and aggressive form of primary brain tumors …

Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reaction

X Li, Y Cheng, Z Yang, Q Ji, M Huan, W Ye… - Journal of …, 2024 - Springer
Glioma is easy to develop resistance to temozolomide (TMZ). TMZ-resistant glioma secretes
interleukin-10 (IL-10) and transforming growth factor-β (TGF-β), recruiting regulatory T cell …

Development of a novel glycolysis-related genes signature for isocitrate dehydrogenase 1-associated glioblastoma multiforme

X Cai, Z Chen, C Huang, J Shen, W Zeng… - Frontiers in …, 2022 - frontiersin.org
Background The significant difference in prognosis between IDH1 wild-type and IDH1
mutant glioblastoma multiforme (GBM) may be attributed to their metabolic discrepancies …

Radiotherapy for pediatric low-grade glioma

I Bansal, TE Merchant - Child's Nervous System, 2024 - Springer
Methods This review by Indu Bansal and Thomas E. Merchant examines the indications,
timing, and results of radiotherapy for pediatric low-grade glioma. The authors provide a …

Prognostic role of BRAF mutation in low-grade Gliomas: meta-analysis

Z Kai, L Dingyang, Y Zhuanyi - World neurosurgery, 2021 - Elsevier
Objective Newly emerged molecular markers in gliomas provide prognostic values beyond
the capabilities of histologic classification. BRAF mutation, especially BRAF V600E, is …

Thromboembolic toxicity observed with concurrent trametinib and lenalidomide therapy

PP Chan, A Sabus, MS Hemenway… - Pediatric blood & …, 2023 - Wiley Online Library
The event‐free survival of pediatric low‐grade gliomas is poor, and patients often require
multiple treatment strategies. While MEK and RAF inhibitors are efficacious in early‐phase …